SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

BioArctic Presents Lecanemab Binding Profile at CTAD

BioArctic will present lecanemab’s binding profile at the CTAD congress.

Related stories